Patents by Inventor Mark A. Demitrack

Mark A. Demitrack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240025949
    Abstract: This application describes a family of compounds acting as beta-arrestin effectors that can be used, for example, for treating acute respiratory distress syndrome, for preventing and treating thrombosis, platelet adhesion, and platelet aggregation, and/or for reducing a D-Dimer response, in a subject with ARDS or a viral infection, such as a coronavirus infection.
    Type: Application
    Filed: September 30, 2022
    Publication date: January 25, 2024
    Inventor: Mark Demitrack
  • Publication number: 20230114241
    Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of S1P1 receptor and methods of using the same for the treatment of seizures, epilepsy related conditions, epilepsy-related syndrome, and the like as described herein.
    Type: Application
    Filed: September 3, 2020
    Publication date: April 13, 2023
    Inventors: Mark A. DEMITRACK, Michael S. KRAMER
  • Publication number: 20210324005
    Abstract: This application describes a family of compounds acting as ?-arrestin effectors that can be used, for example, for treating acute respiratory distress syndrome, for preventing and treating thrombosis, platelet adhesion, and platelet aggregation, and/or for reducing a D-Dimer response, in a subject with ARDS or a viral infection, such as a coronavirus infection.
    Type: Application
    Filed: April 20, 2021
    Publication date: October 21, 2021
    Inventor: Mark A. Demitrack